Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

FDA-Cleared treatment is based on proven techniques and designed for lasting remission. Luma Therapeutics, a company dedicated to eradicating suffering from inflammatory skin disease, announced the launch of an innovative light-based therapy for the treatment of plaque psoriasis. The company’s FDA-cleared breakthrough technology, the illuvinate System, is an in-home treatment designed to provide lasting relief from psoriasis symptoms. Illuvinate can now be prescribed either by a dermatologist or via Luma’s telehealth provider, HealthLens.

Read more ...

Opening the door to personalized medicine. SUN bioscience launches its Gri3D™ platform. Industrialized with CSEM technological support, Gri3D enables the large-scale, standardized, rapid, and reliable production of 3-D in vitro organoid cultures from patient stem cells. This groundbreaking, large scale standardizing of organoids represents a key advancement toward truly personalizing medicine.

Read more ...

The US Food and Drug Administration announced a proposal to establish procedures and criteria for the de novo classification of medical devices, including in vitro diagnostics. FDA Commissioner Scott Gottlieb said in a statement that the agency's goal is to make the pathway "significantly more efficient and transparent by clarifying the requirements for submission and our processes for review."

Read more ...

GenEdit, a developer of novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics, announced the completion of a $8.5 million Series Seed financing round led by new investors Data Collective Bio (DCVC Bio) and SK Holdings. Also participating in the round are pre-seed investors, including Sequoia Capital and Bow Capital. DCVC Bio Managing Partner, Kiersten Stead, Ph.D., and Natera co-founder and CEO, Matthew Rabinowitz, Ph.D., joined GenEdit's Board of Directors.

Read more ...

The ECG app on Apple Watch Series 4 marks the first direct-to-consumer product that enables customers to take an electrocardiogram right from their wrist, capturing heart rhythm in a moment when they experience symptoms like a rapid or skipped heart beat and helping to provide critical data to physicians.

Read more ...

Genomic Health, the world's provider of genomic-based diagnostic tests and Biocartis, an innovative molecular diagnostics company, announced they have expanded their exclusive collaboration into the field of urology with the development of an in vitro diagnostic (IVD) version of the Oncotype DX Genomic Prostate Score (GPS) test on Biocartis' Idylla platform and potentially additional cancer tests that can be performed locally by laboratory partners and in hospitals around the world.

Read more ...

Upcoming Events

No events

Presentation

Micromachined Ultrasound Technologies: An Overview of Emerging Trends and Applications
Discover the presentation held by Jérôme Mouly, Senior Technology & Market Analyst, Inkjet...
CRISPR Technology & Market Overview: challenges, market competition landscape and strategic opportunities
Discover the presentation held by Asma Siari, Technology & Market Analyst in Biotechnologies...
Birth of a Future Giant: Zoom on the Chinese Microfluidics Industry
Discover the presentation held by Sébastien Clerc, Market & Technology Analyst, Microfluidi...

Access to all our presentations